Work

Protocol of Study 2 from Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Year: 2023
Type: other
Abstract: CG1006-CAR-GPC3 T cells clinical trial
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361816232
Cites:
Cited by:
Related to: 10